These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 39001570)
1. Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysis. Giménez-Palomo A; Chamdal AK; Gottlieb N; Lotfaliany M; Jokinen T; Bastawy EM; Adlington K; Benachar N; Dodd S; Pacchiarotti I; Vieta E; Berk M; Stokes PRA Acta Psychiatr Scand; 2024 Jul; ():. PubMed ID: 39001570 [TBL] [Abstract][Full Text] [Related]
2. MAOIs in the contemporary treatment of depression. Thase ME; Trivedi MH; Rush AJ Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154 [TBL] [Abstract][Full Text] [Related]
3. Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: A systematic review and network meta-analysis. Suchting R; Tirumalajaru V; Gareeb R; Bockmann T; de Dios C; Aickareth J; Pinjari O; Soares JC; Cowen PJ; Selvaraj S J Affect Disord; 2021 Mar; 282():1153-1160. PubMed ID: 33601690 [TBL] [Abstract][Full Text] [Related]
4. Current place of monoamine oxidase inhibitors in the treatment of depression. Shulman KI; Herrmann N; Walker SE CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Thomas SJ; Shin M; McInnis MG; Bostwick JR Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531 [TBL] [Abstract][Full Text] [Related]
6. Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine. Hoffman GR; Olson MG; Schoffstall AM; Estévez RF; Van den Eynde V; Gillman PK; Stabio ME ACS Chem Neurosci; 2023 Dec; 14(23):4064-4075. PubMed ID: 37966854 [TBL] [Abstract][Full Text] [Related]
7. Treatment of depression with atypical features: a meta-analytic approach. Henkel V; Mergl R; Allgaier AK; Kohnen R; Möller HJ; Hegerl U Psychiatry Res; 2006 Jan; 141(1):89-101. PubMed ID: 16321446 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Lotufo-Neto F; Trivedi M; Thase ME Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
10. Antidepressants versus placebo for panic disorder in adults. Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793 [TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitors. A perspective on their use in the elderly. Volz HP; Gleiter CH Drugs Aging; 1998 Nov; 13(5):341-55. PubMed ID: 9829163 [TBL] [Abstract][Full Text] [Related]
12. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. Ketter TA; Post RM; Parekh PI; Worthington K J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374 [TBL] [Abstract][Full Text] [Related]
13. MAOIs - does the evidence warrant their resurrection? Menkes D; Bosanac P; Castle D Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855 [TBL] [Abstract][Full Text] [Related]
14. Treating DSM-IV depression with atypical features. Stewart JW; Thase ME J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800 [TBL] [Abstract][Full Text] [Related]